ASPC 2018 Congress on CVD Prevention

 

ASPC 2018 Congress on CVD Prevention
Avatar

Debate – Pro – Lipoprotein(a) – Should Be Measured In All Patients At Higher CVD Risk

By ASPC 2018 Congress on CVD Prevention FEATURING Patrick Moriarty
By ASPC 2018 Congress on CVD Prevention FEATURING Patrick Moriarty
833 views
August 10, 2018
2 Comments
Login to view comments. Click here to Login

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus
SESSION 8 - Debate Potpourri/Debate
25:28
ASPC 2018 Congress on CVD Prevention

What We Know and Don’t Know About Coronary Artery Calcium Imaging

Feat. K. Nasir
24:39
ASPC 2018 Congress on CVD Prevention

Screening and Anticoagulation for Afib – New Options and Opportuniti…

16:12
ASPC 2018 Congress on CVD Prevention

Debate – Pro – Lipoprotein(a) – Should Be Measured In All Patients A…

Feat. P. Moriarty
13:27
ASPC 2018 Congress on CVD Prevention

Debate – Con – Lipoprotein(a) – There is Nothing You Can Do About It…

Feat. S. Fazio
12:33
ASPC 2018 Congress on CVD Prevention

ASPC 2018 Congress on CVD Prevention: Discussion